{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-011774","form_type":"8-K","ticker":"RFL","cik":"0001713863","company_name":"Rafael Holdings, Inc.","filed_at":"2025-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.560618+00:00","generated_at":"2026-05-27T00:13:25.111044+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Rafael Holdings and Cyclo Therapeutics extend merger deadline to March 31, 2025","bullets":["Amendment No. 2 to Merger Agreement extends the End Date from February 15, 2025 to March 31, 2025.","Rafael Holdings holds approximately 39.5% of Cyclo Therapeutics' outstanding common stock.","Extension allows additional time for SEC to declare the Form S-4 registration statement effective."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-011774","json":"https://secwatch.observer/filing/0001213900-25-011774.json","markdown":"https://secwatch.observer/filing/0001213900-25-011774.md","text":"https://secwatch.observer/filing/0001213900-25-011774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1713863/000121390025011774/0001213900-25-011774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1713863/000121390025011774/ea0230532-8k_rafael.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:13:25.111044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}